Please select the option that best describes you:
Topics:
Hepatology • Viral Hepatitis
How do you approach the management of a patient who has both chronic hepatitis B (treatment naive, elevated ALT, viral load >1million) and MASLD with NILDA showing advanced fibrosis?
Do you preferentially or more aggressively treat one cause of chronic liver disease over the other? Does management of cardiometabolic risk factors improve their outcomes related to hepatitis B?